Literature DB >> 21039645

A mock circulatory system with physiological distribution of terminal resistance and compliance: application for testing the intra-aortic balloon pump.

Christina Kolyva1, Giovanni Biglino, John R Pepper, Ashraf W Khir.   

Abstract

A mock circulatory system (MCS) was designed to replicate a physiological environment for in vitro testing and was assessed with the intra-aortic balloon pump (IABP). The MCS was comprised of an artificial left ventricle (LV), connected to a 14-branch polyurethane-compound aortic model. Physiological distribution of terminal resistance and compliance according to published data was implemented with capillary tubes of different sizes and syringes of varying air volume, respectively, fitted at the outlets of the branches. The ends of the aortic branches were connected to a common tube representing the venous system and an overhead reservoir provided atrial pressure. An IABP operating a 40-cc balloon was set to counterpulsate with the LV. Total arterial compliance of the system was 0.94 mL/mm Hg and total arterial resistance was 20.3 ± 3.3 mm Hg/L/min. At control, physiological flow distribution was achieved and both mean and phasic aortic pressure and flow were physiological. With the IABP, aortic pressure exhibited the major features of counterpulsation: diastolic augmentation during inflation, inflection point at onset of deflation, and end-diastolic reduction at the end of deflation. The contribution of balloon inflation and deflation was also evident on the aortic flow pattern. This MCS was verified to be suitable for IABP testing and with further adaptations it could be used for studying other hemodynamic problems and ventricular assist devices.
© 2010, Copyright the Authors. Artificial Organs © 2010, International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21039645     DOI: 10.1111/j.1525-1594.2010.01071.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  7 in total

1.  Newly Shaped Intra-Aortic Balloons Improve the Performance of Counterpulsation at the Semirecumbent Position: An In Vitro Study.

Authors:  Christina Kolyva; John R Pepper; Ashraf W Khir
Journal:  Artif Organs       Date:  2016-08       Impact factor: 3.094

2.  Three-Dimensional Printed Polylactic Acid (PLA) Surgical Retractors with Sonochemically Immobilized Silver Nanoparticles: The Next Generation of Low-Cost Antimicrobial Surgery Equipment.

Authors:  Lazaros Tzounis; Petros I Bangeas; Aristomenis Exadaktylos; Markos Petousis; Nectarios Vidakis
Journal:  Nanomaterials (Basel)       Date:  2020-05-21       Impact factor: 5.076

3.  A structural approach to 3D-printing arterial phantoms with physiologically comparable mechanical characteristics: Preliminary observations.

Authors:  Bruce Guest; Luis Arroyo; John Runciman
Journal:  Proc Inst Mech Eng H       Date:  2022-08-01       Impact factor: 1.763

4.  A Mock Circulatory System Incorporating a Compliant 3D-Printed Anatomical Model to Investigate Pulmonary Hemodynamics.

Authors:  Paul G M Knoops; Giovanni Biglino; Alun D Hughes; Kim H Parker; Linzhang Xu; Silvia Schievano; Ryo Torii
Journal:  Artif Organs       Date:  2016-12-07       Impact factor: 3.094

5.  Rapid prototyping compliant arterial phantoms for in-vitro studies and device testing.

Authors:  Giovanni Biglino; Peter Verschueren; Raf Zegels; Andrew M Taylor; Silvia Schievano
Journal:  J Cardiovasc Magn Reson       Date:  2013-01-16       Impact factor: 5.364

6.  Measurements of Intra-Aortic Balloon Wall Movement During Inflation and Deflation: Effects of Angulation.

Authors:  Gianpaolo Bruti; Christina Kolyva; John R Pepper; Ashraf W Khir
Journal:  Artif Organs       Date:  2015-05-08       Impact factor: 3.094

Review 7.  Role of innovative 3D printing models in the management of hepatobiliary malignancies.

Authors:  Peter Bangeas; Vassilios Tsioukas; Vasileios N Papadopoulos; Georgios Tsoulfas
Journal:  World J Hepatol       Date:  2019-07-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.